Hybrid Session: The International Working Group on the Economics of Disease Elimination and Integration (IWG-EDEI)
Global Institute for Disease Elimination (GLIDE)
Global Hepatitis C Elimination: Experience and the Road Ahead
Ministry of Health and Welfare, Taiwan
Operationalizing the Lung Cancer Agenda: A Pathway to Measurable Progress
Swedish Institute for Health Economics (IHE), Lung Cancer Policy Network, MSD
Readiness, reach, results: strengthening health systems in low- and middle-income countries (LMICs) for NCD care
Boehringer Ingelheim
Building people-centred cancer systems: advancing rights, equity and support across the care pathway
Union for International Cancer Control (UICC)
Innovation Demo Day
WHO Traditional Medicine, Bayer Foundation; Reckitt, Bioprevail, Health Innovation Exchange (HIEx)
Promoting Inovation in Antimicrobia Resistance: Prevention, Diagnosis and Treatment
Infectious Disease Alliance (IDA), Active Citizenship Network (ACN)
Second GCM Participants Gathering
World Health Organization (WHO) – Global Coordination Mechanism
The Obesity‚ Liver Connection: Shaping the Future of Metabolic Care
Boehringer Ingelheim
Adequate and sustained financing for NCDs and Mental Health: approaches to closing the implementation gap
NCD Alliance, Barbados, United for Global Mental Health, Philippines, UNDP